BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET
BioHarvest Sciences (NASDAQ: BHST) has announced an upcoming Virtual Investor Webinar scheduled for September 10, 2025, at 1:00 PM ET. CEO Ilan Sobel will lead the presentation, focusing on new capability-building initiatives and the company's strategic 'Big Bets' for the second half of 2025.
The webinar will cover updates on both consumer and CDMO business units, including progress on the Health Pros program, hydration product development, and key CDMO efforts. Participants can join via phone or webcast, with playback available through September 24, 2025.
BioHarvest Sciences (NASDAQ: BHST) ha annunciato un webinar virtuale per investitori previsto per il 10 settembre 2025 alle 13:00 ET. Il CEO Ilan Sobel guiderà la presentazione, concentrandosi sulle nuove iniziative di sviluppo delle capacità e sulle strategie chiave («Big Bets») per la seconda metà del 2025.
Il webinar fornirà aggiornamenti sulle unità consumer e CDMO, compresi i progressi del programma Health Pros, lo sviluppo di un prodotto per l’idratazione e gli sforzi principali del CDMO. I partecipanti potranno collegarsi via telefono o webcast; la registrazione sarà disponibile fino al 24 settembre 2025.
BioHarvest Sciences (NASDAQ: BHST) ha anunciado un seminario web virtual para inversores programado para el 10 de septiembre de 2025 a la 1:00 PM ET. El CEO Ilan Sobel dirigirá la presentación, centrada en nuevas iniciativas para ampliar capacidades y en las apuestas estratégicas ('Big Bets') de la compañía para la segunda mitad de 2025.
El webinar ofrecerá actualizaciones sobre las unidades de negocio de consumo y CDMO, incluyendo avances en el programa Health Pros, el desarrollo de un producto de hidratación y los principales esfuerzos del CDMO. Los participantes podrán unirse por teléfono o webcast; la reproducción estará disponible hasta el 24 de septiembre de 2025.
BioHarvest Sciences (NASDAQ: BHST)는 2025년 9월 10일 오후 1:00(동부시간)에 예정된 온라인(가상) 투자자 웨비나를 발표했습니다. CEO Ilan Sobel가 발표를 이끌며, 역량 강화 신규 이니셔티브와 2025년 하반기 회사의 전략적 'Big Bets'에 중점을 둘 예정입니다.
웨비나에서는 소비자 사업부와 CDMO(위탁개발생산) 사업부의 업데이트를 다루며, Health Pros 프로그램 진행 상황, 수분 보충 제품 개발, 주요 CDMO 활동 등에 대해 설명합니다. 참가자는 전화나 웹캐스트로 참여할 수 있으며, 재생은 2025년 9월 24일까지 제공됩니다.
BioHarvest Sciences (NASDAQ: BHST) a annoncé un webinaire virtuel pour les investisseurs prévu le 10 septembre 2025 à 13h00 ET. Le PDG Ilan Sobel dirigera la présentation, en mettant l'accent sur de nouvelles initiatives de renforcement des capacités et sur les « Big Bets » stratégiques de l'entreprise pour le second semestre 2025.
Le webinaire abordera des mises à jour sur les divisions grand public et CDMO, y compris les progrès du programme Health Pros, le développement d'un produit hydratant et les principaux efforts du CDMO. Les participants pourront se joindre par téléphone ou webcast; la lecture sera disponible jusqu'au 24 septembre 2025.
BioHarvest Sciences (NASDAQ: BHST) hat ein bevorstehendes virtuelles Investoren-Webinar angekündigt, das für den 10. September 2025 um 13:00 Uhr ET angesetzt ist. CEO Ilan Sobel wird die Präsentation leiten und sich auf neue Kapazitätsaufbau-Initiativen sowie die strategischen 'Big Bets' des Unternehmens für das zweite Halbjahr 2025 konzentrieren.
Das Webinar wird Updates zu den Geschäftsbereichen Consumer und CDMO enthalten, einschließlich Fortschritten im Health Pros-Programm, der Entwicklung eines Hydratationsprodukts und wesentlichen CDMO-Aktivitäten. Teilnehmer können per Telefon oder Webcast teilnehmen; die Wiedergabe ist bis zum 24. September 2025 verfügbar.
- None.
- None.
Rehovot, Israel--(Newsfile Corp. - September 2, 2025) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will host a Virtual Investor Webinar on Wednesday, September 10, 2025 at 1:00 p.m. Eastern time.
CEO Ilan Sobel will host the virtual investor webinar to provide a corporate update on new capability-building initiatives, the Company's 'Big Bets' for 2H 2025, and will conclude with a question-and-answer session from dial-in participants. To attend, please reference the access information below:
Virtual Investor Webinar
Date: Wednesday, September 10, 2025
Time: 1:00 p.m. Eastern time
U.S./Canada Dial-in: 1-877-300-8521
International Dial-in: 1-412-317-6026
Conference ID: 10202632
Webcast: BHST Virtual Investor Webinar
Sobel said: "This upcoming virtual investor webinar provides a fantastic opportunity to discuss new developments across both our consumer and CDMO business units. We look forward to providing a progress update on our 'Big Bets' as outlined in our most recent earnings call - such as our Health Pros program, hydration product and key CDMO efforts - as well as dive into exciting new capability-building technology initiatives. As we broaden our product offerings and expand our CDMO pipeline, we remain focused on driving profitable growth and delivering long-term value to my fellow shareholders."
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
A telephone playback of the call will be available through Wednesday, September 24, 2025. To listen, call 1-844-512-2921 within the United States and Canada or 1-412-317-6671 when calling internationally, using replay pin number 10202632. A webcast replay will also be available at the webcast link above.
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) is a leader in Botanical Synthesis, leveraging its patented technology platform to grow the active ingredients in plants, without the need to grow the underlying plant. BioHarvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules, and as a creator of proprietary nutraceutical health and wellness products, which includes dietary supplements. To learn more, please visit www.bioharvest.com.
Forward-Looking Statements
Information set forth in this news release might include forward-looking statements that are based on management's current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHST does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures.
BioHarvest Corporate Contact:
Dave Ryan, VP Investor Relations
(604) 622-1186
info@bioharvest.com
Investor Relations Contact:
Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
(949) 259-4987
BHST@mzgroup.us
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/264724
FAQ
When is BioHarvest Sciences (BHST) hosting its Virtual Investor Webinar?
How can investors access the BHST Virtual Investor Webinar?
What topics will be covered in BioHarvest Sciences' September 2025 investor webinar?
How long will the BHST webinar replay be available?
